Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

C-C chemokine receptor type 2 mediates glomerular injury and interstitial fibrosis in focal segmental glomerulosclerosis.

Wilkening A, Krappe J, Mühe AM, Lindenmeyer MT, Eltrich N, Luckow B, Vielhauer V.

Nephrol Dial Transplant. 2018 Dec 28. doi: 10.1093/ndt/gfy380. [Epub ahead of print]

PMID:
30597038
2.

CCL2 Is a Vascular Permeability Factor Inducing CCR2-Dependent Endothelial Retraction during Lung Metastasis.

Roblek M, Protsyuk D, Becker PF, Stefanescu C, Gorzelanny C, Glaus Garzon JF, Knopfova L, Heikenwalder M, Luckow B, Schneider SW, Borsig L.

Mol Cancer Res. 2019 Mar;17(3):783-793. doi: 10.1158/1541-7786.MCR-18-0530. Epub 2018 Dec 14.

PMID:
30552233
3.

Ly6Chigh Monocytes Oscillate in the Heart During Homeostasis and After Myocardial Infarction-Brief Report.

Schloss MJ, Hilby M, Nitz K, Guillamat Prats R, Ferraro B, Leoni G, Soehnlein O, Kessler T, He W, Luckow B, Horckmans M, Weber C, Duchene J, Steffens S.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1640-1645. doi: 10.1161/ATVBAHA.117.309259. Epub 2017 Jun 29.

PMID:
28663258
4.

Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara.

Price PJ, Luckow B, Torres-Domínguez LE, Brandmüller C, Zorn J, Kirschning CJ, Sutter G, Lehmann MH.

J Virol. 2014 Sep;88(18):10840-50. doi: 10.1128/JVI.01524-14. Epub 2014 Jul 9.

5.

Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways.

Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, Wieghofer P, Heinrich A, Riemke P, Hölscher C, Müller DN, Luckow B, Brocker T, Debowski K, Fritz G, Opdenakker G, Diefenbach A, Biber K, Heikenwalder M, Geissmann F, Rosenbauer F, Prinz M.

Nat Neurosci. 2013 Mar;16(3):273-80. doi: 10.1038/nn.3318. Epub 2013 Jan 20.

PMID:
23334579
6.

Globosides but not isoglobosides can impact the development of invariant NKT cells and their interaction with dendritic cells.

Porubsky S, Speak AO, Salio M, Jennemann R, Bonrouhi M, Zafarulla R, Singh Y, Dyson J, Luckow B, Lehuen A, Malle E, Müthing J, Platt FM, Cerundolo V, Gröne HJ.

J Immunol. 2012 Sep 15;189(6):3007-17. doi: 10.4049/jimmunol.1201483. Epub 2012 Aug 8.

7.

C-C motif chemokine CCL3 and canonical neutrophil attractants promote neutrophil extravasation through common and distinct mechanisms.

Reichel CA, Puhr-Westerheide D, Zuchtriegel G, Uhl B, Berberich N, Zahler S, Wymann MP, Luckow B, Krombach F.

Blood. 2012 Jul 26;120(4):880-90. doi: 10.1182/blood-2012-01-402164. Epub 2012 Jun 6.

8.

Rhoh deficiency reduces peripheral T-cell function and attenuates allogenic transplant rejection.

Porubsky S, Wang S, Kiss E, Dehmel S, Bonrouhi M, Dorn T, Luckow B, Brakebusch C, Gröne HJ.

Eur J Immunol. 2011 Jan;41(1):76-88. doi: 10.1002/eji.201040420. Epub 2010 Nov 11.

9.

Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome.

Dehmel S, Wang S, Schmidt C, Kiss E, Loewe RP, Chilla S, Schlöndorff D, Gröne HJ, Luckow B.

Eur J Immunol. 2010 Jan;40(1):267-78. doi: 10.1002/eji.200939652.

10.

Microinjection of Cre recombinase protein into zygotes enables specific deletion of two eukaryotic selection cassettes and enhances the expression of a DsRed2 reporter gene in Ccr2/Ccr5 double-deficient mice.

Luckow B, Hänggli A, Maier H, Chilla S, Loewe RP, Dehmel S, Schlöndorff D, Loetscher P, Zerwes HG, Müller M.

Genesis. 2009 Aug;47(8):545-58. doi: 10.1002/dvg.20531.

PMID:
19517561
11.

[Glycosphingolipids Gb3 and iGb3. In vivo roles in hemolytic-uremic syndrome and iNKT cell function].

Porubsky S, Luckow B, Bonrouhi M, Speak A, Cerundolo V, Platt F, Gröne HJ.

Pathologe. 2008 Nov;29 Suppl 2:297-302. doi: 10.1007/s00292-008-1040-0. German.

PMID:
18810447
12.

The chemokine receptor Cxcr3 is not essential for acute cardiac allograft rejection in mice and rats.

Zerwes HG, Li J, Kovarik J, Streiff M, Hofmann M, Roth L, Luyten M, Pally C, Loewe RP, Wieczorek G, Bänteli R, Thoma G, Luckow B.

Am J Transplant. 2008 Aug;8(8):1604-13. doi: 10.1111/j.1600-6143.2008.02309.x. Epub 2008 Jun 28.

13.

Prevalence of CCR5Delta32 polymorphism in long-term survivors of heart transplantation.

Luckow B.

Transpl Immunol. 2007 Nov;18(2):198-9; author reply 200-2. Epub 2007 Oct 17. No abstract available.

PMID:
18005868
14.

Targeting of Gr-1+,CCR2+ monocytes in collagen-induced arthritis.

Brühl H, Cihak J, Plachý J, Kunz-Schughart L, Niedermeier M, Denzel A, Rodriguez Gomez M, Talke Y, Luckow B, Stangassinger M, Mack M.

Arthritis Rheum. 2007 Sep;56(9):2975-85.

15.

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency.

Porubsky S, Speak AO, Luckow B, Cerundolo V, Platt FM, Gröne HJ.

Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5977-82. Epub 2007 Mar 19.

16.

Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice.

Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C.

Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):373-9. Epub 2006 Nov 30.

PMID:
17138939
17.

Chemokine receptors Ccr1, Ccr2, and Ccr5 mediate neutrophil migration to postischemic tissue.

Reichel CA, Khandoga A, Anders HJ, Schlöndorff D, Luckow B, Krombach F.

J Leukoc Biol. 2006 Jan;79(1):114-22. Epub 2005 Nov 7.

PMID:
16275892
18.

Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.

Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.

J Am Soc Nephrol. 2005 Dec;16(12):3592-601. Epub 2005 Nov 2.

19.

Simultaneous blockade of NFkappaB, JNK, and p38 MAPK by a kinase-inactive mutant of the protein kinase TAK1 sensitizes cells to apoptosis and affects a distinct spectrum of tumor necrosis factor [corrected] target genes.

Thiefes A, Wolter S, Mushinski JF, Hoffmann E, Dittrich-Breiholz O, Graue N, Dörrie A, Schneider H, Wirth D, Luckow B, Resch K, Kracht M.

J Biol Chem. 2005 Jul 29;280(30):27728-41. Epub 2005 Apr 18. Erratum in: J Biol Chem. 2005 Sep 16;280(37):32564.

20.

Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease.

Ninichuk V, Gross O, Reichel C, Khandoga A, Pawar RD, Ciubar R, Segerer S, Belemezova E, Radomska E, Luckow B, Perez de Lema G, Murphy PM, Gao JL, Henger A, Kretzler M, Horuk R, Weber M, Krombach F, Schlöndorff D, Anders HJ.

J Am Soc Nephrol. 2005 Apr;16(4):977-85. Epub 2005 Feb 16.

21.

Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.

Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.

Kidney Int. 2004 Sep;66(3):1018-28.

22.

Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice.

Luckow B, Joergensen J, Chilla S, Li JP, Henger A, Kiss E, Wieczorek G, Roth L, Hartmann N, Hoffmann R, Kretzler M, Nelson PJ, Pérez de Lema G, Maier H, Wurst W, Balling R, Pfeffer K, Gröne HJ, Schlöndorff D, Zerwes HG.

Eur J Immunol. 2004 Sep;34(9):2568-78.

23.

Evolutionary genetics: Ambiguous role of CCR5 in Y. pestis infection.

Elvin SJ, Williamson ED, Scott JC, Smith JN, Pérez De Lema G, Chilla S, Clapham P, Pfeffer K, Schlöndorff D, Luckow B.

Nature. 2004 Jul 22;430(6998):417.

PMID:
15272490
24.

Chemokine receptor CCR1 but not CCR5 mediates leukocyte recruitment and subsequent renal fibrosis after unilateral ureteral obstruction.

Eis V, Luckow B, Vielhauer V, Siveke JT, Linde Y, Segerer S, Perez De Lema G, Cohen CD, Kretzler M, Mack M, Horuk R, Murphy PM, Gao JL, Hudkins KL, Alpers CE, Gröne HJ, Schlöndorff D, Anders HJ.

J Am Soc Nephrol. 2004 Feb;15(2):337-47.

25.

Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice.

Pérez De Lema G, De Wit C, Cohen CD, Nieto E, Molina A, Banas B, Luckow B, Vicente AB, Mampaso F, Schlöndorff D.

J Pharmacol Exp Ther. 2003 Oct;307(1):275-81. Epub 2003 Sep 3.

PMID:
12954793
26.

Phenotyping renal leukocyte subsets by four-color flow cytometry: characterization of chemokine receptor expression.

Vielhauer V, Anders HJ, Pérez de Lema G, Luckow B, Schlöndorff D, Mack M.

Nephron Exp Nephrol. 2003;93(2):e63.

PMID:
12629274
27.

Chemokine receptor 5 expression in gastric mucosa of Helicobacter pylori-infected and noninfected children.

Krauss-Etschmann S, Sammler E, Koletzko S, Konstantopoulos N, Aust D, Gebert B, Luckow B, Reinhardt D, Schendel DJ.

Clin Diagn Lab Immunol. 2003 Jan;10(1):22-9.

28.

Modulation of HIV-1 enhancer activity and virus production by cAMP.

Banas B, Eberle J, Banas B, Schlöndorff D, Luckow B.

FEBS Lett. 2001 Dec 7;509(2):207-12.

29.

Identification of new regulatory sequences far upstream of the mouse monocyte chemoattractant protein-1 gene.

Wagner K, Dendorfer U, Chilla S, Schlöndorff D, Luckow B.

Genomics. 2001 Dec;78(3):113-23.

PMID:
11735217
30.

Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.

Pérez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlöndorff D.

J Am Soc Nephrol. 2001 Jul;12(7):1369-82.

31.

CC chemokine receptor 5 and renal-transplant survival.

Fischereder M, Luckow B, Hocher B, Wüthrich RP, Rothenpieler U, Schneeberger H, Panzer U, Stahl RA, Hauser IA, Budde K, Neumayer H, Krämer BK, Land W, Schlöndorff D.

Lancet. 2001 Jun 2;357(9270):1758-61.

PMID:
11403814
32.

Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes.

Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, Stangassinger M, Luckow B, Gröne HJ, Schlöndorff D.

J Am Soc Nephrol. 2001 Jun;12(6):1173-87.

33.

Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis.

Anders HJ, Vielhauer V, Kretzler M, Cohen CD, Segerer S, Luckow B, Weller L, Gröne HJ, Schlöndorff D.

J Am Soc Nephrol. 2001 May;12(5):919-31.

34.

Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice.

Mack M, Cihak J, Simonis C, Luckow B, Proudfoot AE, Plachý J, Brühl H, Frink M, Anders HJ, Vielhauer V, Pfirstinger J, Stangassinger M, Schlöndorff D.

J Immunol. 2001 Apr 1;166(7):4697-704.

35.

The mCK-5 multiprobe RNase protection assay kit can yield erroneous results for the murine chemokines IP-10 and MCP-1.

Luckow B, Maier H, Chilla S, Pérez de Lema G.

Anal Biochem. 2000 Nov 15;286(2):193-7.

PMID:
11067740
36.

The apoptosis mediator mDAP-3 is a novel member of a conserved family of mitochondrial proteins.

Berger T, Brigl M, Herrmann JM, Vielhauer V, Luckow B, Schlöndorff D, Kretzler M.

J Cell Sci. 2000 Oct;113 ( Pt 20):3603-12.

37.

Expression of chemokines and their receptors in nephrotoxic serum nephritis.

Schadde E, Kretzler M, Banas B, Luckow B, Assmann K, Schlöndorff D.

Nephrol Dial Transplant. 2000 Jul;15(7):1046-53.

PMID:
10862646
38.

Chemokine and chemokine receptor expression in a novel human mesangial cell line.

Banas B, Luckow B, Möller M, Klier C, Nelson PJ, Schadde E, Brigl M, Halevy D, Holthöfer H, Reinhart B, Schlöndorff D.

J Am Soc Nephrol. 1999 Nov;10(11):2314-22.

39.

Transcriptional regulation of the interleukin-6 gene in mesangial cells.

Grassl C, Luckow B, Schlöndorff D, Dendorfer U.

J Am Soc Nephrol. 1999 Jul;10(7):1466-77.

40.

HIV-1-infected long-term slow progressors heterozygous for delta32-CCR5 show significantly lower plasma viral load than wild-type slow progressors.

Walli R, Reinhart B, Luckow B, Lederer E, Loch O, Malo A, Wank R, Schlöndorff D, Goebel FD.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1;18(3):229-33.

PMID:
9665499
41.

Genetic basis of adenylosuccinase deficiency in an Italian patient.

Verginelli D, Luckow B, Salerno C, Gross M.

Adv Exp Med Biol. 1998;431:323-5. No abstract available.

PMID:
9598084
42.

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.

Mack M, Luckow B, Nelson PJ, Cihak J, Simmons G, Clapham PR, Signoret N, Marsh M, Stangassinger M, Borlat F, Wells TN, Schlöndorff D, Proudfoot AE.

J Exp Med. 1998 Apr 20;187(8):1215-24.

43.

Identification of new mutations in the adenylosuccinate lyase gene associated with impaired enzyme activity in lymphocytes and red blood cells.

Verginelli D, Luckow B, Crifò C, Salerno C, Gross M.

Biochim Biophys Acta. 1998 Feb 27;1406(1):81-4.

44.

CFTR mRNA and its truncated splice variant (TRN-CFTR) are differentially expressed during collecting duct ontogeny.

Huber S, Braun G, Burger-Kentischer A, Reinhart B, Luckow B, Horster M.

FEBS Lett. 1998 Feb 27;423(3):362-6.

45.

Immortalization and characterization of human peritoneal mesothelial cells.

Fischereder M, Luckow B, Sitter T, Schröppel B, Banas B, Schlöndorff D.

Kidney Int. 1997 Jun;51(6):2006-12. No abstract available.

46.

Specific cleavage of the large subunit of replication factor C in apoptosis is mediated by CPP32-like protease.

Song Q, Lu H, Zhang N, Luckow B, Shah G, Poirier G, Lavin M.

Biochem Biophys Res Commun. 1997 Apr 17;233(2):343-8.

PMID:
9144536
47.

Regulation of RANTES and ICAM-1 expression in murine mesangial cells.

Satriano JA, Banas B, Luckow B, Nelson P, Schlondorff DO.

J Am Soc Nephrol. 1997 Apr;8(4):596-603.

48.

Chemokines and renal disease.

Schlöndorff D, Nelson PJ, Luckow B, Banas B.

Kidney Int. 1997 Mar;51(3):610-21. Review. No abstract available.

49.

The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution.

Kaestner KH, Hiemisch H, Luckow B, Schütz G.

Genomics. 1994 Apr;20(3):377-85.

PMID:
8034310
50.

Supplemental Content

Loading ...
Support Center